ICD10 Disease Category |
Disease Name |
ICD10 Code |
Associated Disease Targets (Association Ref: TTD database) |
L00-L99: Diseases of the skin and subcutaneous tissue |
Pruritus |
L29 |
ALOX5; |
N00-N99: Diseases of the genitourinary system |
Prostate disease |
N42.9 |
CYP19A1; |
J00-J99: Diseases of the respiratory system |
Adult respiratory distress syndrome |
J80 |
F3; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Insomnia |
F51.0, G47.0 |
CA2; |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
ALOX5; |
E00-E89: Endocrine, nutritional and metabolic diseases |
Non-insulin dependent diabetes |
E11.9 |
FFAR1; |
I00-I99: Diseases of the circulatory system |
Neurological disease |
I21, I22, R52, R52.1-R52.2, R60.9, G89 |
NPSR1; |
G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
MAOA; |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
MAPK1; TP53; |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
ALOX5; |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
ALOX5; |
J00-J99: Diseases of the respiratory system |
Respiratory disease |
J00-J99 |
ALOX5; |
I00-I99: Diseases of the circulatory system |
Restenosis |
I51.89 |
MAPK1; |
H60-H95: Diseases of the ear and mastoid process |
Hearing disorder |
H90.5 |
TP53; |
C00-D49: Neoplasms |
Oral cavity cancer |
C00-C08 |
TP53; |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoarthritis |
M15-M19, M47 |
ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
ALOX5; |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
FFAR1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Depression |
F30-F39 |
MAOA; |
H00-H59: Diseases of the eye and adnexa |
Open-angle glaucoma |
H40-H42 |
CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
FFAR1; |
L00-L99: Diseases of the skin and subcutaneous tissue |
Dermatitis |
L20-L30 |
ALOX5; |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Toxicity |
T36-T50, T51-T65 |
TP53; |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR; |
I00-I99: Diseases of the circulatory system |
Renal artery disease |
I70.1 |
TP53; |
I00-I99: Diseases of the circulatory system |
High blood pressure |
I10-I16 |
CA2; |
C00-D49: Neoplasms |
Hormonally-responsive breast cancer |
C50 |
CYP19A1; |
C00-D49: Neoplasms |
Head and neck cancer |
C07-C14, C32-C33 |
TP53; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR; |
J00-J99: Diseases of the respiratory system |
Rhinitis |
J00, J30, J31.0 |
ALOX5; |
C00-D49: Neoplasms |
Hematological malignancies |
C81-C86 |
TP53; |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
TP53; |
C00-D49: Neoplasms |
Late-stage solid tumors |
C00-C75, C7A, C7B, D10-D36, D3A |
TP53; |
N00-N99: Diseases of the genitourinary system |
Endometriosis |
N80 |
CYP19A1; |
I00-I99: Diseases of the circulatory system |
Edema associated with congestive heart failure |
I50, R60.9 |
CA2; |
L00-L99: Diseases of the skin and subcutaneous tissue |
Psoriasis |
L40 |
ALOX5; |
G00-G99: Diseases of the nervous system G00-G99 |
Epilepsy |
G40 |
MAOA; |
K00-K95: Diseases of the digestive system |
Duodenal ulcers |
K25-K27 |
CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Mood disorder |
F30-F39 |
MAOA; |
A00-B99: Certain infectious and parasitic diseases |
Fungal infections |
B35-B49 |
ALOX5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Alcohol use disorders |
F10.2 |
MAOA; |
J00-J99: Diseases of the respiratory system |
Chronic obstructive pulmonary disease |
J40-J44, J47 |
ALOX5; |
A00-B99: Certain infectious and parasitic diseases |
Lymphatic filariasis |
B74 |
ALOX5; |
C00-D49: Neoplasms |
Breast cancer |
C50 |
CYP19A1; |
C00-D49: Neoplasms |
Advanced breast cancer |
C50 |
CYP19A1; |
NA: NA |
Edema |
NA |
CA2; |
C00-D49: Neoplasms |
Bladder cancer |
C67 |
CYP19A1; |
I00-I99: Diseases of the circulatory system |
Bleeding |
I74, I80-I82 |
F3; |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR; |
C00-D49: Neoplasms |
Pancreatic cancer |
C25 |
F3; |
G00-G99: Diseases of the nervous system G00-G99 |
Parkinson's disease |
G20 |
MAOA; |
I00-I99: Diseases of the circulatory system |
Thrombosis |
I80-I82 |
ALOX5; |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Allergy |
T78.4 |
ALOX5; |
C00-D49: Neoplasms |
Acute myeloid leukemia |
C92.0 |
TP53; |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
MAPK1; TP53; |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue |
Vitiligo |
L80 |
MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
MAOA; |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
MAOA; PTGES; |
E00-E89: Endocrine, nutritional and metabolic diseases |
Inflammation |
E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 |
ALOX5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive disorder |
F32, F33, M32 |
MAOA; |